Silaghi Horatiu, Pop Laura Ancuța, Georgescu Carmen Emanuela, Muntean Diana, Crișan Doinița, Silaghi Patricia, Lungu Ionela, Nasui Bogdana Adriana, Dulf Eva-H, Braicu Cornelia, Berindan-Neagoe Ioana, Silaghi Cristina Alina
Department of Surgery V, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
Biomedicines. 2024 Jan 9;12(1):136. doi: 10.3390/biomedicines12010136.
Recent research has revealed the importance of miRNAs in the diagnosis and clinical evolution of papillary thyroid cancer (PTC). We aim to identify a specific miRNA profile that could differentiate between specific subtypes of PTC.
In this cross-sectional study, total RNA was extracted from paraffin-embedded tissues of 43 patients, 17 with an infiltrative follicular variant of PTC (iFVPTC) and 26 with a conventional variant of PTC (cPTC). Nine miRNAs were evaluated using qRT-PCR technology and specific miRNA assays.
We found specific patterns for cPTC and iFVPTC, such as miRNA altered in both types of tumours (miR-146b-5p, miR-181a-5p, miR-221-3p, miR-21-5p and miR-222-3p) and two miRNAs significantly expressed only in cPTC (miR-20b-5p, miR-21-5p). The iFVPTC group presented strong and moderate correlations between miRNA expression and clinical data. miR-221-3p, miR-195-5p, miR-181-5p, miR-146b-5p and miR-222 were correlated with age, tumour size (TS) or lymph node metastases (N), while only miR-20b-5p, miR-195-5p and miR-181-5p were correlated with TS, N and age in the cPTC group.
The present study allowed the identification of a signature of two miRNAs to confirm miRNA differences between the two histological subtypes of TC. Our results provide advances in the molecular diagnosis of TC and could help to improve the diagnostic performance of already existing molecular classifiers.
近期研究揭示了微小RNA(miRNA)在甲状腺乳头状癌(PTC)诊断及临床进展中的重要性。我们旨在确定一种能区分PTC特定亚型的特定miRNA谱。
在这项横断面研究中,从43例患者的石蜡包埋组织中提取总RNA,其中17例为PTC浸润性滤泡变体(iFVPTC),26例为PTC传统变体(cPTC)。使用定量逆转录聚合酶链反应(qRT-PCR)技术和特定的miRNA检测方法对9种miRNA进行评估。
我们发现了cPTC和iFVPTC的特定模式,如在两种肿瘤中均发生改变的miRNA(miR-146b-5p、miR-181a-5p、miR-221-3p、miR-21-5p和miR-222-3p)以及仅在cPTC中显著表达的两种miRNA(miR-20b-5p、miR-21-5p)。iFVPTC组miRNA表达与临床数据之间呈现强相关性和中度相关性。miR-221-3p、miR-195-5p、miR-181-5p、miR-146b-5p和miR-222与年龄、肿瘤大小(TS)或淋巴结转移(N)相关,而在cPTC组中,仅miR-20b-5p、miR-195-5p和miR-181-5p与TS、N和年龄相关。
本研究确定了两种miRNA的特征,以证实甲状腺癌两种组织学亚型之间的miRNA差异。我们的结果为甲状腺癌的分子诊断提供了进展,并有助于提高现有分子分类器的诊断性能。